Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway

MLA

Weilan Lan, et al. “Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.” Anti-Cancer Agents in Medicinal Chemistry, vol. 21, Sept. 2021, pp. 1987–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0605d24673c296f8aba4f3ab46632cd3&authtype=sso&custid=ns315887.

APA

Weilan Lan, Haixia Shang, Jiumao Lin, Jun Peng, Wujin Chen, & Jinyan Zhao. (2021). Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway. Anti-Cancer Agents in Medicinal Chemistry, 21, 1987–1995.

Chicago

Weilan Lan, Haixia Shang, Jiumao Lin, Jun Peng, Wujin Chen, and Jinyan Zhao. 2021. “Anlotinib Overcomes Multiple Drug Resistant Colorectal Cancer Cells via Inactivating PI3K/AKT Pathway.” Anti-Cancer Agents in Medicinal Chemistry 21 (September): 1987–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0605d24673c296f8aba4f3ab46632cd3&authtype=sso&custid=ns315887.